Antibacterial and Biofilm-Targeting Performance of Cefuroxime Axetil-Loaded Eudragit® Nanoparticles
Antibiotics · 12.11.2026 · 15 (11) · 1130
DOI: 10.3390/antibiotics15111130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 12.11.2026. Verfasst von Pervin Soyer und 3 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anadolu University.
Abstract (Originalsprache)
Background/Objectives: Cefuroxime axetil (CA) is a poorly water-soluble second-generation cephalosporin. This study aimed to develop CA-loaded Eudragit® RS100/RL100 nanoparticles (NPs) and investigate the influence of polymer composition and drug-to-polymer ratio on their physicochemical, antibacterial, and antibiofilm properties.
Methods
Six CA-loaded NPs (NP-1–NP-6) were prepared using nano spray drying with Eudragit® RS100, RL100, or their 1:1 mixture at drug-to-polymer ratios of 1:1 and 1:2. Particle characteristics, drug content, and structural properties were evaluated. Antibacterial activity was assessed using agar well diffusion, broth microdilution, and time-kill assays, while antibiofilm activity against pre-established Staphylococcus aureus and Escherichia coli biofilms was determined using crystal violet staining. Additional analyses included drug-content-normalized MIC, MIC-normalized time-kill exposure, and concentration–response area under the curve (AUC).
Results
All drug-loaded NPs retained antibacterial activity and reduced established biofilm biomass, whereas blank NPs showed no detectable activity. FT-IR and 1H-NMR analyses indicated no evidence of new covalent interactions. Free CA exhibited greater planktonic antibacterial potency, including after drug-content normalization. Among the NPs, NP-1 showed the most favorable MIC profile, while MIC-normalized time-kill analysis revealed NP-dependent exposure differences without consistent bactericidal activity. At 500 µg/mL, all CA-loaded NPs reduced biofilm biomass by more than 95% against both bacterial species. NP-6 exhibited the highest numerical antibiofilm AUC values against S. aureus (133.37) and E. coli (128.85), although these differences were descriptive and did not establish statistical superiority.
Conclusions
CA-loaded Eudragit® NPs demonstrated formulation-dependent antibacterial and antibiofilm responses, with NP-1 performing favorably in planktonic inhibition and NP-6 in integrated biofilm biomass reduction. These findings support further investigation of Eudragit®-based antibiotic delivery systems, although superiority over free CA and therapeutic advantages remain unverified.
Förderung
- Anadolu University
Zitieren
APA
Soyer, P., Çevikelli, T., Bölgen, U. M. G., & Öztürk, A. A. (2026). Antibacterial and Biofilm-Targeting Performance of Cefuroxime Axetil-Loaded Eudragit® Nanoparticles. Antibiotics, 15(11), 1130. https://doi.org/10.3390/antibiotics15111130
Vancouver
Soyer P, Çevikelli T, Bölgen UMG, Öztürk AA. Antibacterial and Biofilm-Targeting Performance of Cefuroxime Axetil-Loaded Eudragit® Nanoparticles. Antibiotics. 2026;15(11):1130. doi:10.3390/antibiotics15111130
BibTeX
@article{Soyer2026,
author = {Soyer, Pervin and Çevikelli, Tilbe and Bölgen, Umay Merve Güven and Öztürk, A. Alper},
title = {Antibacterial and Biofilm-Targeting Performance of Cefuroxime Axetil-Loaded Eudragit® Nanoparticles},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {11},
pages = {1130},
doi = {10.3390/antibiotics15111130}
}
EUVIMED